dlbcl disease specific programme (dsp)tm database (Adelphi Technology Inc)
90
Structured Review
Adelphi Technology Inc
dlbcl disease specific programme (dsp)tm database
Dlbcl Disease Specific Programme (Dsp)tm Database, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/database+programmer/disease+specific+program++dsp+/pmc11228594-261-7-6
Average 90 stars, based on 1 article reviews
Dlbcl Disease Specific Programme (Dsp)tm Database, supplied by Adelphi Technology Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/database+programmer/disease+specific+program++dsp+/pmc11228594-261-7-6
Average 90 stars, based on 1 article reviews
dlbcl disease specific programme (dsp)tm database - by Bioz Stars,
2026-11
90/100 stars
Images
1) Product Images from "Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey"
Article Title: Real-world evaluation of health-related quality of life in patients with diffuse large B-cell lymphoma based on a multinational survey
Journal: Frontiers in Oncology
doi: 10.3389/fonc.2024.1402992
Figure Legend Snippet: Demographics and clinical characteristics of patients with DLBCL.
Techniques Used:
Figure Legend Snippet: Bivariate analysis comparing EORTC QLQ-C30 scores for patients with DLBCL vs NHL reference values* † .
Techniques Used:
Figure Legend Snippet: Disease burden of patients with DLBCL, by country: bivariate analysis.
Techniques Used: Activity Assay
Figure Legend Snippet: Disease burden of patients with DLBCL, by line of therapy: bivariate analysis.
Techniques Used: Comparison, Activity Assay
Figure Legend Snippet: Utility/functioning factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).
Techniques Used:
Figure Legend Snippet: Symptom factors associated with QoL for patients with DLBCL (statistically significant factors for PRO scores).
Techniques Used: Activity Assay
Figure Legend Snippet: Symptom burden of patients with DLBCL, by line of therapy.
Techniques Used:
Figure Legend Snippet: Overall physician- and patient-reported symptoms experienced by patients with DLBCL.
Techniques Used:
Figure Legend Snippet: Adverse events experienced by patients with DLBCL, by line of therapy.
Techniques Used:
Related Articles
other:Article Title: Special Issue: European Epilepsy Congress Abstract Issue. Article Snippet: 15th European Epilepsy Congress 7–11 September 2024 | Rome, Italy Article Title: Equity and Outcome Events in Hidradenitis Suppurativa: Exploring Effect Modifiers Associated with Diagnostic Delay in the Real World. Article Snippet: The data source used was the Article Title: Equity and Outcome Events in Hidradenitis Suppurativa: Exploring Effect Modifiers Associated with Diagnostic Delay in the Real World. Article Snippet: Clinical and demographic data from the Article Title: Real-World Experience with an Adalimumab Biosimilar (ABP 501) in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis and Psoriasis in Europe: Results from the Adelphi Disease Specific Programme Article Snippet: Data were drawn from the RA, spondyloarthritis, and Article Title: Health-related quality of life and symptom concordance between patients and physicians in pulmonary arterial hypertension in the United States, Europe, and Japan. Article Snippet: Data were drawn from the Article Title: Health-related quality of life and productivity burden for non-professional caregivers of adults with rare diseases: a real-world study. Article Snippet: This was a retrospective analysis of physician- and caregiver-reported data drawn from six Biomarker Discovery:Article Title: Equity and Outcome Events in Hidradenitis Suppurativa: Exploring Effect Modifiers Associated with Diagnostic Delay in the Real World Article Snippet: .. Clinical and demographic data from the |